1. Home
  2. GOSS vs CPSS Comparison

GOSS vs CPSS Comparison

Compare GOSS & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • CPSS
  • Stock Information
  • Founded
  • GOSS 2015
  • CPSS 1991
  • Country
  • GOSS United States
  • CPSS United States
  • Employees
  • GOSS N/A
  • CPSS N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • CPSS Finance: Consumer Services
  • Sector
  • GOSS Health Care
  • CPSS Finance
  • Exchange
  • GOSS Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • GOSS 212.9M
  • CPSS 233.1M
  • IPO Year
  • GOSS 2019
  • CPSS 1992
  • Fundamental
  • Price
  • GOSS $0.80
  • CPSS $10.89
  • Analyst Decision
  • GOSS Strong Buy
  • CPSS
  • Analyst Count
  • GOSS 5
  • CPSS 0
  • Target Price
  • GOSS $9.20
  • CPSS N/A
  • AVG Volume (30 Days)
  • GOSS 2.3M
  • CPSS 28.9K
  • Earning Date
  • GOSS 11-07-2024
  • CPSS 10-31-2024
  • Dividend Yield
  • GOSS N/A
  • CPSS N/A
  • EPS Growth
  • GOSS N/A
  • CPSS N/A
  • EPS
  • GOSS N/A
  • CPSS 0.87
  • Revenue
  • GOSS $105,322,000.00
  • CPSS $184,246,000.00
  • Revenue This Year
  • GOSS N/A
  • CPSS N/A
  • Revenue Next Year
  • GOSS N/A
  • CPSS $17.21
  • P/E Ratio
  • GOSS N/A
  • CPSS $12.87
  • Revenue Growth
  • GOSS N/A
  • CPSS N/A
  • 52 Week Low
  • GOSS $0.50
  • CPSS $7.03
  • 52 Week High
  • GOSS $1.60
  • CPSS $12.04
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 50.75
  • CPSS 58.43
  • Support Level
  • GOSS $0.83
  • CPSS $10.54
  • Resistance Level
  • GOSS $1.10
  • CPSS $11.30
  • Average True Range (ATR)
  • GOSS 0.08
  • CPSS 0.39
  • MACD
  • GOSS 0.02
  • CPSS 0.01
  • Stochastic Oscillator
  • GOSS 31.66
  • CPSS 63.16

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S.-based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent, by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: